On March 12, the United States District Court for the Southern District of Indiana joined the District of Delaware and Eastern District of Texas as the first courts to consider a generic drug manufacturer’s motion to dismiss...more
3/18/2015
/ Abbreviated New Drug Application (ANDA) ,
DaimlerChrysler v Bauman ,
Forum ,
Generic Drugs ,
Hatch-Waxman ,
Minimum Contacts ,
Motion to Dismiss ,
Patent Infringement ,
Patents ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Popular